Blog
01-04-2023Cross-posted from FDA News Release [On December 22, 2022], the U.S. Food and Drug Administration approved Sunle...
FDA
FDA Approves New HIV Drug for Adults with Limited Treatment Options - Blog
Participants Needed in Blood Donor Study: Could Lead to Eligibility Changes for Men Who Have Sex with Men 01-26-2022 - Blog
FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV 01-22-2021 - Blog
Federal Agencies Highlight Ongoing Efforts to End HIV for World AIDS Day 12-07-2020 - Blog
FDA Approves New HIV Treatment for Patients With Limited Treatment Options 07-14-2020 - Blog
FDA Approves Drug to Treat Infants and Children with HIV 06-16-2020 - Blog
New FDA Information on OraQuick In-Home HIV Test 06-11-2020 - Blog
President Trump Announces Remdesivir Authorized for Emergency COVID-19 Treatment, Discusses Ending HIV and Hepatitis C 05-05-2020 - Blog
Coronavirus (COVID-19) Update: FDA Provides Updated Guidance to Address the Urgent Need for Blood During the Pandemic 04-02-2020Among others, the FDA is making the following changes, for immediate implementation, to the December 2015 guidance:For male donors who would have been deferred.… - Blog
FDA Launches Mobile-Friendly Database with Information on Life-Saving HIV Drugs 02-06-2020 - Blog
FDA’s Response to HIV: A Perspective from the Commissioner 10-03-2019 - Blog
FDA Approves First Two-drug Complete Regimen for HIV-infected Patients Who Have Never Received Antiretroviral Treatment 04-09-2019 - Blog
Secretary Azar Addresses CDC’s National HIV Prevention Conference 03-20-2019The featured speaker was Secretary of Health and Human Services Alex Azar, who discussed Ending the HIV Epidemic: A Plan for America, the Administration s Pl... - Blog
Recent HIV News from FDA 05-30-2018On May 14, 2018, the FDA announced the availability of a draft guidance entitled Pediatric HIV Infection: Drug Development for Treatment and invited publ... - Blog
FDA Approves First Two-Drug Regimen for Certain Patients with HIV 11-27-2017 - Blog
FDA HIV Update: Approval of Generic Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg 06-29-2017 - Blog
FDA Requests Removal of Opana ER for Risks Related to Abuse 06-29-2017Crossposted from FDA Newsroom Note: Earlier this month, the FDA requested that a drug company remove an opioid pain medication, Opana ER, from the market becau.… - Blog
FDA Requests Removal of Opana ER for Risks Related to Abuse 06-29-2017 - Blog
Health Information on the Web 03-07-2017Millions of consumers are using digital media to get health information, applications to monitor health conditions, and social media to find people who share s.… - Blog
FDA approves Epclusa for treatment of chronic Hepatitis C virus infection 06-30-2016